Weekly round up from Life Sciences Industry.
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has completed its previously announced acquisition of SentreHEART, Inc., a privately held developer of percutaneous left atrial appendage management solutions.
Date: August 19, 2019
Source: Business Wire
Sign up for DistilINFO e-Newsletters.
OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology
Top 6 Digital Transformation Trends In Healthcare For 2019
Sony Study Reinforces Importance of Remote Monitoring
Voiceitt, Cisco Partner to Offer Speech Recognition for Virtual Meetings
Personalized Screening is Key to Breast Imaging AI Market Reaching $205M By 2025
Summit Healthcare REIT, Inc. acquires an interest in 14 skilled nursing/assisted living facilities in Indiana
61 Health Tech Companies Report 2018 Revenues, Feature On Inc. 5,000 List
Worldwide Active Pharmaceutical Ingredient Industry to 2026 – Featuring Pfizer, AbbVie and Novartis Among Others – ResearchAndMarkets.com